BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7543572)

  • 1. Neuropeptide metabolism on intact, regional brain slices: effect of dopaminergic agents on substance P, cholecystokinin and Met-enkephalin degradation.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):783-9. PubMed ID: 7543572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and apomorphine differentially affect neuropeptidase activity.
    Waters SM; Konkoy CS; Davis TP
    J Pharmacol Exp Ther; 1996 Apr; 277(1):113-20. PubMed ID: 8613907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute administration of neuroleptics decreases neurotensin metabolism on intact, regional rat brain slices.
    Konkoy CS; Waters SM; Davis TP
    J Pharmacol Exp Ther; 1994 May; 269(2):555-63. PubMed ID: 7910209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional metabolism of Met-enkephalin and cholecystokinin on intact ratbrain slices: characterization of specific peptidases.
    Konkoy CS; Davis TP
    J Neurochem; 1995 Dec; 65(6):2773-82. PubMed ID: 7595577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lithium and haloperidol administration on the rat brain levels of substance P.
    Hong JS; Tilson HA; Yoshikawa K
    J Pharmacol Exp Ther; 1983 Mar; 224(3):590-3. PubMed ID: 6186804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of inherent and drug-induced dopaminergic activity after exposure to benzo(alpha)pyrene.
    Konstandi M; Harkitis P; Thermos K; Ogren SO; Johnson EO; Tzimas P; Marselos M
    Neurotoxicology; 2007 Jul; 28(4):860-7. PubMed ID: 17570529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance P depresses excitatory synaptic transmission in the nucleus accumbens through dopaminergic and purinergic mechanisms.
    Kombian SB; Ananthalakshmi KV; Parvathy SS; Matowe WC
    J Neurophysiol; 2003 Feb; 89(2):728-37. PubMed ID: 12574450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do neuropeptide systems mediate some of the effects of antipsychotic drugs?
    Bissette G; Nemeroff CB
    Prog Clin Biol Res; 1985; 192():349-53. PubMed ID: 2867552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substance P (SP) heptapeptide fragment SP1-7 alters the density of dopamine receptors in rat brain mesocorticolimbic structures during morphine withdrawal.
    Zhou Q; Kindlundh AM; Hallberg M; Nyberg F
    Peptides; 2004 Nov; 25(11):1951-7. PubMed ID: 15501527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
    Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
    Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacitracin-sensitive aminopeptidase(s) degradation of methionine(5)-enkephalin by human brain putamen and hippocampus preparations: inhibition by phenothiazine drugs.
    Mosnaim AD; Saavedra R; Wolf ME
    Am J Ther; 2009; 16(6):512-6. PubMed ID: 19797941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of Met-enkephalin, Leu-enkephalin, substance P and cholecystokinin in the brain of the common marmoset following long term 1-methyl-4-phenyl-1,2,3,6,-tetrahydropyridine treatment.
    Taquet H; Nomoto M; Rose S; Jenner P; Javoy-Agid F; Mauborgne A; Benoliel JJ; Marsden CD; Legrand JC; Agid Y
    Neuropeptides; 1988 Oct; 12(3):105-10. PubMed ID: 2468106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY) and its mRNA in discrete brain areas after subchronic administration of neuroleptics.
    Herman ZS
    Acta Neurobiol Exp (Wars); 1996; 56(1):55-61. PubMed ID: 8787211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
    Sivam SP; Cox J
    Brain Res; 2006 Feb; 1073-1074():159-63. PubMed ID: 16455064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal degradation of cholecystokinin-(29-33)-amide in mouse brain is dependent on tripeptidyl peptidase-I: implications for the degradation and storage of peptides in classical late-infantile neuronal ceroid lipofuscinosis.
    Bernardini F; Warburton MJ
    Biochem J; 2002 Sep; 366(Pt 2):521-9. PubMed ID: 12038963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study on the pharmacological properties of atypical antipsychotic drugs: in vivo dopamine and serotonin receptor occupancy by atypical antipsychotic drugs in the rat brain].
    Matsubara R
    Hokkaido Igaku Zasshi; 1993 Jul; 68(4):570-82. PubMed ID: 7687976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatments with haloperidol and clozapine alter the level of NMDA-R1 mRNA in the rat brain: an in situ hybridization study.
    Ossowska K; Pietraszek M; Wardas J; Dziedzicka-Wasylewska M; Nowicka D; Wolfarth S
    Pol J Pharmacol; 2002; 54(1):1-9. PubMed ID: 12020038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased haloperidol-induced potentiation of zif268 mRNA expression in the nucleus accumbens shell and the dorsal lateral striatum of rats lacking cholecystokinin-A receptors.
    Shilling PD; Feifel D
    Synapse; 2002 Feb; 43(2):134-8. PubMed ID: 11754493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
    Van De Witte SV; Groenewegen HJ; Voorn P
    Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.